This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Verrotti, A. Articles by Chiarelli, F. Search for Related Content PubMed PubMed Citation Articles by Verrotti, A. Articles by Chiarelli, F. Social Bookmarking                   What's this?

Insulin Resistance in Epileptic Girls Who Gain Weight After Therapy With Valproic Acid

Department of Medicine, Section of Pediatrics University of Chieti, Chieti, Italy

Fania Basciani, RD

Department of Medicine, Section of Pediatrics University of Chieti, Chieti, Italy

Michele De Simone, MD

Department of Pediatrics University of L'Aquila, L'Aquila, Italy, Department of Pediatrics, University of Siena, Siena, Italy

Daniela Trotta, MD

Department of Medicine, Section of Pediatrics University of Chieti, Chieti, Italy

Guido Morgese, MD

Department of Medicine, Section of Pediatrics University of Chieti, Chieti, Italy

Francesco Chiarelli, MD

Department of Medicine, Section of Pediatrics University of Chieti, Chieti, Italy

Valproic acid is effective for treatment of many types of epilepsy, but its use in epileptic patients can be associated with an increase in body weight that could interfere with treatment compliance. The weight gain may result from different mechanisms, but the exact pathogenesis is still unknown. To evaluate insulin sensitivity in adolescents who gained weight during treatment with valproic acid, we studied 20 girls with different types of epilepsy: 15 patients had primary generalized seizures, including absence seizures (3 cases), and 5 patients had partial seizures. After 1 year of valproic acid treatment, the obese patients had serum insulin levels significantly higher than patients who did not gain weight (51.4 ± 25.3 versus 28.2 ± 12.9). Moreover, we observed that epileptic patients who gained weight were also insulin resistant in comparison with nonobese epileptic subjects. At the end of treatment, all patients showed normal levels of serum testosterone, androstenedione, dehydroepiandrosterone sulfate, follicle-stimulating hormone (FSH), and luteinizing hormone. We found no significant correlation between insulinemia and serum valproic acid concentrations in obese and nonobese patients treated with valproic acid. Our study demonstrates that basal hyperinsulinemia and insulin resistance can be present in patients who develop obesity during valproic acid treatment. Therefore, these obese patients could be exposed to the risks related to these metabolic abnormalities; if these data are confirmed in longer studies, these side effects may raise some concerns about the safety of valproic acid. (J Child Neurol 2002;17:265-268).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. J. Steinhoff Optimizing therapy of seizures in patients with endocrine disorders Neurology, December 26, 2006; 67(12_suppl_4): S23 - S27. [Abstract] [Full Text]

				L. Qiao, J. Schaack, and J. Shao Suppression of Adiponectin Gene Expression by Histone Deacetylase Inhibitor Valproic Acid Endocrinology, February 1, 2006; 147(2): 865 - 874. [Abstract] [Full Text] [PDF]

				R. Greco, G. Latini, F. Chiarelli, P. Iannetti, and A. Verrotti Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid Neurology, December 13, 2005; 65(11): 1808 - 1809. [Abstract] [Full Text] [PDF]

				K. Aydin, A. Serdaroglu, C. Okuyaz, A. Bideci, and K. Gucuyener Serum Insulin, Leptin, and Neuropeptide Y Levels in Epileptic Children Treated With Valproate J Child Neurol, October 1, 2005; 20(10): 848 - 851. [Abstract] [PDF]

				V. L. Nelson-DeGrave, J. K. Wickenheisser, J. E. Cockrell, J. R. Wood, R. S. Legro, J. F. Strauss III, and J. M. McAllister Valproate Potentiates Androgen Biosynthesis in Human Ovarian Theca Cells Endocrinology, February 1, 2004; 145(2): 799 - 808. [Abstract] [Full Text] [PDF]

				S. Wu, A. Legido, and F. De Luca Effects of Valproic Acid on Longitudinal Bone Growth J Child Neurol, January 1, 2004; 19(1): 26 - 30. [Abstract] [PDF]

				M. Bosnak, B. Dikici, K. Haspolat, A. Dagli, and S. Dikici Do Epileptic Children Treated With Valproate Have a Risk of Excessive Weight Gain? J Child Neurol, April 1, 2003; 18(4): 306 - 306. [PDF]

				A. Verrotti, C. Salladini, D. Trotta, G. Morgese, and F. Chiarelli Insulin Resistance in Epileptic Girls Who Gain Weight After Therapy With Valproic Acid: Response to Bosnak et al J Child Neurol, April 1, 2003; 18(4): 306 - 306. [PDF]

				M. Bosnak, B. Dikici, K. Haspolat, A. Dagli, and S. Dikici Do Epileptic Children Treated With Valproate Have a Risk of Excessive Weight Gain? J Child Neurol, April 1, 2003; 18(4): 306 - 306. [PDF]

				A. Verrotti, C. Salladini, D. Trotta, G. Morgese, and F. Chiarelli Insulin Resistance in Epileptic Girls Who Gain Weight After Therapy With Valproic Acid: Response to Bosnak et al J Child Neurol, April 1, 2003; 18(4): 306 - 306. [PDF]